![Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis](https://mma.prnewswire.com/media/1385697/klisyri.jpg)
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis
![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Figure2.jpg)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Figure4.jpg)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Mechanism of action of tirbanibulin. Abbreviation: AK, actinic keratosis. | Download Scientific Diagram Mechanism of action of tirbanibulin. Abbreviation: AK, actinic keratosis. | Download Scientific Diagram](https://www.researchgate.net/publication/353433094/figure/fig1/AS:1049084290924545@1627132594836/Mechanism-of-action-of-tirbanibulin-Abbreviation-AK-actinic-keratosis_Q320.jpg)
Mechanism of action of tirbanibulin. Abbreviation: AK, actinic keratosis. | Download Scientific Diagram
![Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results - JDDonline - Journal of Drugs in Dermatology Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results - JDDonline - Journal of Drugs in Dermatology](https://jddonline.com/wp-content/uploads/2020/12/2610J-Open-Access-Article-Promo3-1-scaled.jpg)
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results - JDDonline - Journal of Drugs in Dermatology
![Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Berman_Table1.gif)
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis: New and Emerging Data – JCAD | The Journal of Clinical and Aesthetic Dermatology
![The Medical Letter on Twitter: "Tirbanibulin 1% Ointment (Klisyri) for Actinic Keratosis https://t.co/lkMA2Sbq9h #ActinicKeratosis https://t.co/GyRi3HNEp9" / Twitter The Medical Letter on Twitter: "Tirbanibulin 1% Ointment (Klisyri) for Actinic Keratosis https://t.co/lkMA2Sbq9h #ActinicKeratosis https://t.co/GyRi3HNEp9" / Twitter](https://pbs.twimg.com/media/E0CAuW7XEAAWS3i.png)